Home > Boards > US Listed > Medical - Drugs >

NovaBay Pharmaceuticals, Inc. (NBY)

NBY RSS Feed
Add NBY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/4/2019 11:42:17 AM - Followers: 61 - Board type: Free - Posts Today: 0





 

Corporate Profile
 

ANTI-INFECTIVE COMPOUNDS EFFECTIVE AGAINST BACTERIA, VIRUSES AND FUNGI

NovaBay Pharmaceuticals is a clinical-stage biotechnology company focused on developing its proprietary and patented Aganocide® compounds. Aganocides are novel, broad-spectrum, fast-acting, synthetic anti-infectives designed to mimic the body's defense against infection. They are active against bacteria, fungi and viruses, and are being developed to treat and prevent a wide range of local, non-systemic infections with a low likelihood of developing bacterial resistance.

NOVABAY'S FOUR BUSINESS UNITS

NovaBay is focusing its technology on four distinct therapeutic areas: dermatology, ophthalmology, urology and hospital infections. In dermatology, the focus is on developing NVC-422 gel for impetigo and acne. NovaBay has the advantage of being partnered with Galderma, the leading dermatology company in the world. In ophthalmology, the company anticipates continuing its development of NVC-422 for the treatment of adenoviral conjunctivitis to confirm the encouraging results shown for epidemic keratoconjunctivitis (EKC) seen in the adenoviral conjunctivitis trial. In urology, NovaBay aims to reduce the incidence of urinary catheter blockage and encrustation (UCBE) and the associated urinary tract infections with an irrigation solution containing NVC-422. In hospital infection, NovaBay is targeting the six-million-patient market of chronic non-healing wounds, such as pressure, venous stasis and diabetic ulcers with its proprietary wound cleansing solution containing pure hypochlourus acid solution, NeutroPhase®, which has received two 510(k) clearances from the Food and Drug Administration.

COLLABORATION WITH GALDERMA

NovaBay has entered into and recently expanded an agreement with Galderma S.A. to develop and commercialize Aganocide compounds in acne, impetigo and other dermatological indications.


 

Investor Overview
 

NovaBay Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide® compounds, which are novel, synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells. NovaBay's topical Aganocide compounds are being developed to treat and prevent a wide range of infections without causing bacterial resistance. NovaBay has internal development programs aimed at addressing hospital infections, chronic non-healing wounds, UCBE and onychomycosis.

NovaBay has entered into and recently expanded an agreement with Galderma S.A. to develop and commercialize Aganocide compounds in acne, impetigo and other dermatological indications.


 

Transfer Agent
 

The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. with the following contact information:

For standard US postal mail
Computershare Trust Company, N.A.
Po Box 43070
Providence, RI 02940-3070

For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021

For DWAC instructions provided to brokers
FAST Transfer Agent number - 50173

Telephone and Fax
Toll free in the US +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700


Website
www.computershare.com

eMail inquiries
web.queries@computershare.com

Investor Relations contacts
Theresa Granados
(510) 899-8870
Email Theresa


 

Regulatory Filings - http://www.novabaypharma.com/investors/filings

Share Structure

Market Value- $38,748,193 a/o - Apr 04, 2012

Shares Outstanding - 28,916,562 a/o - Mar 16, 2012

 

2012 Outside News Sources
Publish Date - Headline

Apr 5, 2012 NovaBay Pharmaceuticals Launches CEO Blog
Mar 20, 2012 NovaBay Pharmaceuticals Signs Option Agreement with Virbac Animal Health for Aganocide(R) Compounds
Mar 20, 2012 NovaBay Set for " Phenomenal Year" With Key Upcoming Clinical Data Announcements and Partnership Developments
Mar 6, 2012 NovaBay Pharmaceuticals to Present at Two Upcoming Investor Conferences in March
Feb 29, 2012 NovaBay Issues Statement Regarding Market Activity
Feb 8, 2012 NovaBay Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Feb 7, 2012 NovaBay Pharmaceuticals to Hold Conference Call to Provide Year-End Business Update and 2012 Outlook
Jan 23, 2012 NovaBay Prepares to Launch Global Phase 2b Ophthalmic Study of NVC-422
Jan 9, 2012 NovaBay Pharmaceuticals Announces Strategic Marketing Agreement for NeutroPhase in China


 

SEC Transaction Summary - Last 6 Months
 

Buy/Sell
Buys 2 - Sells 0 - Total 2
Shares Bought 90,000 - Sold 0 - Gross 90,000 - Net 90,000





 

 

NBY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NBY News: Current Report Filing (8-k) 10/10/2019 04:31:16 PM
NBY News: NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia 09/24/2019 06:50:00 AM
NBY News: Current Report Filing (8-k) 09/16/2019 04:31:08 PM
NBY News: NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors 09/16/2019 06:50:00 AM
NBY News: Proxy Statement (definitive) (def 14a) 09/13/2019 08:31:28 AM
PostSubject
#881   matter of time before NBY is over $1 PennystockID2017 10/04/19 11:42:17 AM
#880   kinda quiet @ NBY time for home team Earlofsandwich 10/03/19 02:29:06 PM
#879   NBY keeps getting this spamming video chart to PennystockID2017 09/24/19 08:32:53 PM
#878   * * $NBY Video Chart 09-24-2019 * * ClayTrader 09/24/19 04:05:40 PM
#877   News: $NBY NovaBay Pharmaceuticals Receives Approval for Distribution whytestocks 09/24/19 02:30:58 PM
#876   NBY over $1 today PennystockID2017 09/24/19 09:15:33 AM
#875   * * $NBY Video Chart 09-19-2019 * * ClayTrader 09/19/19 05:56:14 PM
#874   $2-3 easy target! life143 09/19/19 03:06:18 PM
#873   Not sure how to post the chart but life143 09/19/19 02:36:39 PM
#872   I agree, the chart short term and intermidiate Goofachka 09/19/19 01:33:46 PM
#871   We need new,really catalyst to push it up. ttottip 09/19/19 11:44:26 AM
#870   Hey which indicators are you looking at? Goofachka 09/19/19 11:13:16 AM
#869   $NBY chart is just looking amazing, the indicators life143 09/19/19 10:51:52 AM
#867   The steam is running out. ttottip 09/19/19 10:09:29 AM
#866   $NBY $1 today, only 10 am, and volume life143 09/19/19 09:55:50 AM
#865   still waiting.... [SMART MONEY] 09/19/19 08:37:06 AM
#864   please post the news!! [SMART MONEY] 09/18/19 07:31:52 PM
#863   * * $NBY Video Chart 09-18-2019 * * ClayTrader 09/18/19 04:22:38 PM
#862   News!! parrot head 09/18/19 03:34:33 PM
#861   maybe NBY is done dumping on its share holders??? Earlofsandwich 09/16/19 11:38:24 AM
#860   News: $NBY NovaBay Pharmaceuticals Names Finance Executive Jeff whytestocks 09/16/19 08:20:24 AM
#859   * * $NBY Video Chart 09-13-2019 * * ClayTrader 09/13/19 05:26:35 PM
#858   This very strong upward indicator combined with a ttottip 09/12/19 01:48:08 PM
#857   Just it started! ttottip 09/12/19 01:20:52 PM
#856   RSI alert: current RSI(14) is 23.58 Extremely oversold! ttottip 09/11/19 06:14:29 PM
#855   Good prices here to make money. ttottip 09/11/19 04:07:41 PM
#854   * * $NBY Video Chart 09-03-2019 * * ClayTrader 09/03/19 06:02:08 PM
#853   News: $NBY NovaBay Pharmaceuticals to Present at Two whytestocks 09/03/19 10:20:34 AM
#852   any ideas where this stock is heading...? G_R_O_D_T 08/22/19 12:47:49 AM
#851   * * $NBY Video Chart 07-29-2019 * * ClayTrader 07/29/19 04:03:29 PM
#850   Good luck...definitely a good trading opportunity. crudeoil24 07/29/19 03:02:14 PM
#849   I was thinking it was just about to Milo1 07/29/19 03:00:28 PM
#848   Out at 1.46 > appears shorts have full crudeoil24 07/29/19 02:58:10 PM
#847   $2.01 pivot gets $3.75,,then $5.75,,chartit upppp $$$$$$$$ kingsransome 07/29/19 02:39:33 PM
#846   Looks very interesting! Milo1 07/29/19 02:33:34 PM
#845   Earl, definitely good day to buy crudeoil24 07/29/19 12:54:43 PM
#844   NBY is a great $$$$$ opportunity. crudeoil24 07/29/19 12:43:06 PM
#843   Agree! Moving up after this morning's dip! crudeoil24 07/29/19 12:42:34 PM
#842   going to continue to stand with NBY's current Earlofsandwich 07/29/19 10:50:13 AM
#841   News: $NBY NovaBay Pharmaceuticals Reports 2019 Second Quarter whytestocks 07/29/19 09:50:26 AM
#840   selling below private placement just pure stupidity go Earlofsandwich 07/29/19 09:31:49 AM
#839   still loading all i can, NBY on watch Earlofsandwich 07/29/19 07:36:29 AM
#838   wow NBY ON MASSIVE sale now, i have Earlofsandwich 07/24/19 02:05:21 PM
#837   anyone with news about this stock... G_R_O_D_T 07/23/19 04:07:28 PM
#836   seems like this stock is dead...bleeding $$$$ G_R_O_D_T 07/16/19 12:44:27 PM
#835   So NBY headed up some time Wonderful 777 07/11/19 01:48:08 PM
#834   consolidation has been fantastic, every sell is a Earlofsandwich 07/01/19 09:12:50 PM
#833   Holding and adding until we take off into cash_cow1 07/01/19 07:36:05 PM
#832   News: $NBY NovaBay Pharmaceuticals Plan of Compliance Accepted whytestocks 07/01/19 03:10:27 PM
#831   stack em to the roof as gifting continues Earlofsandwich 07/01/19 09:52:38 AM
PostSubject